Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Apr 27, 2026; 18(4): 117517
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.117517
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.117517
Table 1 Comparison of basic characteristics among three groups, mean ± SD/n (%)/median (interquartile range)
| Indicator | Low SI group | Moderate SI group | High SI group | Statistic | P value | Effect size |
| Demographic characteristics | ||||||
| Age (years) | 42.3 ± 15.7 | 45.2 ± 16.9 | 38.6 ± 14.2 | F = 2.847 | 0.061 | η2 = 0.027 |
| Gender (male) | 56 (71.8) | 67 (75.3) | 38 (84.4) | χ2 = 2.831 | 0.243 | Cramer’s V = 0.116 |
| BMI (kg/m2) | 23.4 ± 3.2 | 24.1 ± 3.8 | 22.9 ± 3.5 | F = 1.842 | 0.161 | η2 = 0.017 |
| BMI categories | χ2 = 5.1671 | 0.523 | Cramer’s V = 0.111 | |||
| Normal (18.5-23.9) | 45 (57.7) | 47 (52.8) | 28 (62.2) | |||
| Overweight (24.0-27.9) | 28 (35.9) | 35 (39.3) | 14 (31.1) | |||
| Obese (≥ 28.0) | 5 (6.4) | 7 (7.9) | 3 (6.7) | |||
| Mechanism of injury | χ2 = 12.436 | 0.134 | Cramer’s V = 0.171 | |||
| Traffic accident | 42 (53.8) | 53 (59.6) | 31 (68.9) | |||
| Fall from height | 21 (26.9) | 19 (21.3) | 8 (17.8) | |||
| Heavy object impact | 9 (11.5) | 12 (13.5) | 4 (8.9) | |||
| Sports injury | 4 (5.1) | 3 (3.4) | 1 (2.2) | |||
| Violent injury | 2 (2.6) | 2 (2.2) | 1 (2.2) | |||
| Time-related factors | ||||||
| Time from injury to admission (hours) | 2.1 (1.0-4.2) | 2.5 (1.2-4.8) | 2.8 (1.5-5.1) | H = 3.742 | 0.154 | ε2 = 0.018 |
| Time from admission to surgery (hours) | 4.2 (2.1-7.8) | 2.8 (1.5-5.2) | 1.8 (1.0-3.4) | H = 18.923 | < 0.001 | ε2 = 0.089 |
| Past medical history | ||||||
| Hypertension | 18 (23.1) | 24 (27.0) | 8 (17.8) | χ2 = 1.542 | 0.463 | Cramer’s V = 0.086 |
| Diabetes | 7 (9.0) | 11 (12.4) | 3 (6.7) | χ2 = 1.234 | 0.540 | Cramer’s V = 0.076 |
| Coronary heart disease | 5 (6.4) | 8 (9.0) | 2 (4.4) | χ2 = 1.076 | 0.584 | Cramer’s V = 0.071 |
| Medication history | ||||||
| Anticoagulant use | 4 (5.1) | 6 (6.7) | 2 (4.4) | χ2 = 0.337 | 0.845 | Cramer’s V = 0.040 |
| Antiplatelet drug use | 8 (10.3) | 12 (13.5) | 3 (6.7) | χ2 = 1.543 | 0.462 | Cramer’s V = 0.086 |
| Lifestyle | ||||||
| Smoking history | 32 (41.0) | 38 (42.7) | 21 (46.7) | χ2 = 0.432 | 0.806 | Cramer’s V = 0.045 |
| Alcohol consumption history | 28 (35.9) | 34 (38.2) | 19 (42.2) | χ2 = 0.523 | 0.770 | Cramer’s V = 0.050 |
Table 2 Comparison of clinical indicators at admission among three groups, mean ± SD/n (%)
| Indicator | Low SI group (n = 78) | Moderate SI group (n = 89) | High SI group (n = 45) | Statistic | P value | Effect size | Pairwise comparison P values3 |
| Vital signs | |||||||
| Systolic BP (mmHg) | 128.4 ± 15.2 | 106.3 ± 12.8 | 87.2 ± 11.6 | F = 156.8 | < 0.001 | η2 = 0.600 | P < 0.0014, P < 0.0015, P < 0.0016 |
| Diastolic BP (mmHg) | 78.6 ± 11.4 | 68.2 ± 10.7 | 56.3 ± 9.8 | F = 67.4 | < 0.001 | η2 = 0.392 | P < 0.0014, P < 0.0015, P < 0.0016 |
| Mean arterial pressure (mmHg) | 95.2 ± 11.8 | 80.9 ± 10.4 | 66.6 ± 9.2 | F = 108.7 | < 0.001 | η2 = 0.510 | P < 0.0014, P < 0.0015, P < 0.0016 |
| Heart rate (beats/minutes) | 92.3 ± 12.6 | 118.7 ± 14.2 | 142.8 ± 18.5 | F = 189.3 | < 0.001 | η2 = 0.644 | P < 0.0014, P < 0.0015, P < 0.0016 |
| Respiratory rate (breaths/minutes) | 18.2 ± 2.8 | 21.4 ± 3.6 | 26.8 ± 4.2 | F = 92.6 | < 0.001 | η2 = 0.470 | P < 0.0014, P < 0.0015, P < 0.0016 |
| Body temperature (°C) | 36.8 ± 0.6 | 36.6 ± 0.7 | 36.4 ± 0.8 | F = 4.123 | 0.017 | η2 = 0.0382 | P = 0.1354, P = 0.0165, P = 0.2856 |
| Shock index | 0.72 ± 0.11 | 1.12 ± 0.11 | 1.65 ± 0.28 | F = 892.4 | < 0.001 | η2 = 0.895 | P < 0.0014, P < 0.0015, P < 0.0016 |
| GCS score | |||||||
| Eye opening (E) | 3.8 ± 0.5 | 3.6 ± 0.7 | 3.2 ± 0.9 | F = 12.8 | < 0.001 | η2 = 0.109 | P = 0.0244, P < 0.0015, P = 0.0186 |
| Verbal response (V) | 4.6 ± 0.8 | 4.2 ± 1.1 | 3.7 ± 1.3 | F = 11.2 | < 0.001 | η2 = 0.097 | P = 0.0154, P < 0.0015, P = 0.0456 |
| Motor response (M) | 5.8 ± 0.6 | 5.5 ± 0.9 | 5.1 ± 1.2 | F = 8.9 | < 0.001 | η2 = 0.078 | P = 0.0424, P < 0.0015, P = 0.0786 |
| GCS total score | 14.2 ± 1.4 | 13.3 ± 2.1 | 12.0 ± 2.6 | F = 18.7 | < 0.001 | η2 = 0.152 | P = 0.0064, P < 0.0015, P = 0.0036 |
| GCS grading | χ2 = 14.281 | 0.001 | Cramer’s V = 0.184 | ||||
| Mild (13-15 points) | 72 (92.3) | 73 (82.0) | 30 (66.7) | ||||
| Moderate (9-12 points) | 6 (7.7) | 15 (16.9) | 13 (28.9) | ||||
| Severe (≤ 8 points) | 0 (0.0) | 1 (1.1) | 2 (4.4) | ||||
| Splenic Injury grading | χ2 = 25.671 | < 0.001 | Cramer’s V = 0.246 | ||||
| Grade I | 18 (23.1) | 8 (9.0) | 2 (4.4) | ||||
| Grade II | 32 (41.0) | 25 (28.1) | 6 (13.3) | ||||
| Grade III | 22 (28.2) | 38 (42.7) | 18 (40.0) | ||||
| Grade IV | 5 (6.4) | 15 (16.9) | 15 (33.3) | ||||
| Grade V | 1 (1.3) | 3 (3.4) | 4 (8.9) |
Table 3 Comparison of laboratory test indicators among three groups, mean ± SD
| Indicator | Low SI group | Moderate SI group | High SI group | Statistic | P value | Effect size | Pairwise comparison P values2 |
| Blood routine indicators | |||||||
| Hemoglobin (g/L) | 118.3 ± 18.7 | 96.7 ± 16.4 | 78.2 ± 15.8 | F = 89.6 | < 0.001 | η2 = 0.461 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Red blood cell count (× 1012/L) | 3.94 ± 0.62 | 3.23 ± 0.55 | 2.61 ± 0.53 | F = 87.3 | < 0.001 | η2 = 0.455 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Hematocrit (%) | 35.4 ± 5.6 | 28.9 ± 4.9 | 23.4 ± 4.7 | F = 88.9 | < 0.001 | η2 = 0.459 | P < 0.0013, P < 0.0014, P < 0.0015 |
| White blood cell count (× 109/L) | 9.8 ± 3.2 | 12.4 ± 4.1 | 15.6 ± 5.3 | F = 32.4 | < 0.001 | η2 = 0.237 | P < 0.0013, P < 0.0014, P = 0.0015 |
| Platelet count | 245.6 ± 68.4 | 198.3 ± 58.7 | 128.4 ± 46.2 | F = 42.8 | < 0.001 | η2 = 0.291 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Coagulation function indicators | |||||||
| PT (seconds) | 12.8 ± 1.6 | 14.2 ± 2.1 | 16.8 ± 2.9 | F = 48.9 | < 0.001 | η2 = 0.319 | P < 0.0013, P < 0.0014, P < 0.0015 |
| APTT (seconds) | 32.4 ± 4.8 | 36.7 ± 5.9 | 42.3 ± 7.2 | F = 42.1 | < 0.001 | η2 = 0.287 | P < 0.0013, P < 0.0014, P < 0.0015 |
| INR | 1.08 ± 0.14 | 1.19 ± 0.18 | 1.41 ± 0.24 | F = 45.6 | < 0.001 | η2 = 0.303 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Fibrinogen (g/L) | 3.2 ± 0.8 | 2.8 ± 0.7 | 2.1 ± 0.6 | F = 32.8 | < 0.001 | η2 = 0.239 | P = 0.0033, P < 0.0014, P < 0.0015 |
| Biochemical indicators | |||||||
| Serum creatinine (μmol/L) | 78.4 ± 15.2 | 89.7 ± 18.6 | 112.3 ± 24.8 | F = 48.7 | < 0.001 | η2 = 0.318 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Blood urea nitrogen (mmol/L) | 5.8 ± 1.4 | 7.2 ± 1.8 | 9.6 ± 2.4 | F = 58.9 | < 0.001 | η2 = 0.360 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Total bilirubin (μmol/L) | 18.6 ± 5.2 | 22.4 ± 6.8 | 28.7 ± 8.9 | F = 32.1 | < 0.001 | η2 = 0.235 | P = 0.0023, P < 0.0014, P < 0.0015 |
| ALT (U/L) | 42.3 ± 12.8 | 58.7 ± 18.4 | 78.9 ± 24.6 | F = 56.2 | < 0.001 | η2 = 0.349 | P < 0.0013, P < 0.0014, P < 0.0015 |
| AST (U/L) | 38.9 ± 11.6 | 67.2 ± 20.8 | 95.6 ± 28.4 | F = 102.8 | < 0.001 | η2 = 0.496 | P < 0.0013, P < 0.0014, P < 0.0015 |
| LDH (U/L) | 245.8 ± 58.7 | 324.6 ± 72.9 | 428.7 ± 89.3 | F = 98.4 | < 0.001 | η2 = 0.485 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Electrolyte levels | |||||||
| Serum sodium (mmol/L) | 139.2 ± 3.4 | 138.6 ± 3.8 | 137.1 ± 4.2 | F = 4.89 | 0.008 | η2 = 0.0451 | P = 0.4383, P = 0.0064, P = 0.0635 |
| Serum potassium (mmol/L) | 4.1 ± 0.5 | 4.3 ± 0.6 | 4.6 ± 0.7 | F = 10.8 | < 0.001 | η2 = 0.0941 | P = 0.0453, P < 0.0014, P = 0.0215 |
| Serum chloride (mmol/L) | 103.8 ± 3.2 | 102.9 ± 3.6 | 101.4 ± 4.1 | F = 6.47 | 0.002 | η2= 0.0581 | P = 0.1953, P = 0.0024, P = 0.0515 |
| Blood gas analysis | |||||||
| pH value | 7.38 ± 0.05 | 7.34 ± 0.06 | 7.28 ± 0.08 | F = 39.8 | < 0.001 | η2 = 0.275 | P < 0.0013, P < 0.0014, P < 0.0015 |
| PaO2 (mmHg) | 88.7 ± 12.4 | 82.3 ± 14.7 | 75.1 ± 16.8 | F = 15.9 | < 0.001 | η2 = 0.132 | P = 0.0063, P < 0.0014, P = 0.0215 |
| PaCO2 (mmHg) | 38.2 ± 4.6 | 35.8 ± 5.2 | 32.4 ± 6.1 | F = 18.7 | < 0.001 | η2 = 0.152 | P = 0.0093, P < 0.0014, P = 0.0035 |
| Base excess BE (mmol/L) | -1.2 ± 2.4 | -4.8 ± 3.1 | -8.6 ± 3.8 | F = 89.3 | < 0.001 | η2 = 0.460 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Lactate level (mmol/L) | 2.8 ± 0.9 | 4.6 ± 1.3 | 6.8 ± 1.9 | F = 126.4 | < 0.001 | η2 = 0.547 | P < 0.0013, P < 0.0014, P < 0.0015 |
Table 4 Comparison of imaging examination results among three groups, n (%)
| Indicator | Low SI group | Moderate SI group | High SI group | Statistic | P value | Corrected P value | Effect size | Pairwise comparison P values2 |
| Splenic rupture extent | χ2 = 28.341 | < 0.001 | < 0.001 | Cramer’s V = 0.258 | P = 0.0063, P < 0.0014, P = 0.0245 | |||
| Localized rupture | 45 (57.7) | 28 (31.5) | 7 (15.6) | |||||
| Extensive rupture | 28 (35.9) | 46 (51.7) | 25 (55.6) | |||||
| Shattered rupture | 5 (6.4) | 15 (16.9) | 13 (28.9) | |||||
| Hematoma size | χ2 = 26.881 | < 0.001 | < 0.001 | Cramer’s V = 0.252 | P = 0.0033, P < 0.0014, P = 0.0185 | |||
| Small hematoma (< 5 cm) | 52 (66.7) | 35 (39.3) | 9 (20.0) | |||||
| Medium hematoma (5-10 cm) | 21 (26.9) | 38 (42.7) | 21 (46.7) | |||||
| Large hematoma (> 10 cm) | 5 (6.4) | 16 (18.0) | 15 (33.3) | |||||
| Intraperitoneal hemorrhage volume | χ2 = 42.671 | < 0.001 | < 0.001 | Cramer’s V = 0.317 | P < 0.0013, P < 0.0014, P = 0.0095 | |||
| Small amount | 52 (66.7) | 29 (32.6) | 5 (11.1) | |||||
| Moderate amount | 22 (28.2) | 41 (46.1) | 18 (40.0) | |||||
| Large amount | 4 (5.1) | 19 (21.3) | 22 (48.9) | |||||
| Combined other organ injuries | 25 (32.1) | 42 (47.2) | 28 (62.2) | χ2 = 9.871 | 0.007 | 0.042 | Cramer’s V = 0.216 | P = 0.0423, P = 0.0034, P = 0.1325 |
| Liver injury | 8 (10.3) | 18 (20.2) | 12 (26.7) | χ2 = 5.891 | 0.053 | 0.318 | Cramer’s V = 0.167 | P = 0.0783, P = 0.0214, P = 0.4235 |
| Kidney injury | 6 (7.7) | 12 (13.5) | 8 (17.8) | χ2 = 2.851 | 0.240 | 1.000 | Cramer’s V = 0.116 | P = 0.2343, P = 0.0784, P = 0.5195 |
| Pancreatic injury | 3 (3.8) | 7 (7.9) | 5 (11.1) | χ2 = 2.131 | 0.345 | 1.000 | Cramer’s V = 0.100 | P = 0.3123, P = 0.1294, P = 0.5375 |
| Intestinal injury | 5 (6.4) | 8 (9.0) | 6 (13.3) | χ2 = 1.461 | 0.482 | 1.000 | Cramer’s V = 0.083 | P = 0.5673, P = 0.2134, P = 0.4685 |
| Pelvic fracture | 8 (10.3) | 15 (16.9) | 11 (24.4) | χ2 = 3.841 | 0.147 | 0.882 | Cramer’s V = 0.135 | P = 0.2343, P = 0.0424, P = 0.3245 |
Table 5 Comparison of surgery-related indicators among three groups, n (%)/mean ± SD/median (interquartile range)
| Indicator | Low SI group (n = 78) | Moderate SI group (n = 89) | High SI group (n = 45) | Statistic | P value | Effect size | Pairwise comparison P values2 |
| Surgical timing | χ2 = 25.671 | < 0.001 | Cramer’s V = 0.348 | P = 0.0093, P < 0.0014, P = 0.0035 | |||
| Emergency surgery (< 4 hours) | 28 (35.9) | 52 (58.4) | 38 (84.4) | ||||
| Delayed surgery (≥ 4 hours) | 50 (64.1) | 37 (41.6) | 7 (15.6) | ||||
| Surgical approach | χ2 = 9.847 | 0.007 | Cramer’s V = 0.216 | P = 0.0423, P = 0.0034, P = 0.1325 | |||
| Open splenectomy | 58 (74.4) | 78 (87.6) | 43 (95.6) | ||||
| Laparoscopic splenectomy | 20 (25.6) | 11 (12.4) | 2 (4.4) | ||||
| Operative time (minutes) | 128.4 ± 32.6 | 156.7 ± 41.2 | 167.8 ± 35.4 | F = 23.1 | < 0.001 | η2 = 0.181 | P < 0.0013, P < 0.0014, P = 0.1325 |
| Intraoperative blood loss (mL) | 485.3 ± 124.7 | 732.6 ± 186.4 | 1126.8 ± 268.9 | F = 152.3 | < 0.001 | η2 = 0.593 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Intraoperative transfusion volume | |||||||
| Red blood cells (U) | 2.3 ± 1.8 | 4.6 ± 2.4 | 7.8 ± 3.2 | F = 78.9 | < 0.001 | η2 = 0.430 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Plasma (mL) | 186.4 ± 142.3 | 324.7 ± 198.6 | 542.8 ± 256.4 | F = 48.6 | < 0.001 | η2 = 0.317 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Platelets (U) | 0.2 (0-1.0) | 0.5 (0-1.5) | 1.0 (0-3.0) | H = 18.4 | < 0.001 | ε2 = 0.087 | P = 0.0423, P < 0.0014, P = 0.0155 |
| Intraoperative blood pressure maintenance | χ2 = 37.891 | < 0.001 | Cramer’s V = 0.423 | P < 0.0013, P < 0.0014, P = 0.0065 | |||
| Stable (SBP ≥ 90 mmHg) | 68 (87.2) | 52 (58.4) | 12 (26.7) | ||||
| Unstable (SBP < 90 mmHg) | 10 (12.8) | 37 (41.6) | 33 (73.3) | ||||
| Vasoactive drug use | 12 (15.4) | 34 (38.2) | 32 (71.1) | χ2 = 29.581 | < 0.001 | Cramer’s V = 0.373 | P = 0.0033, P < 0.0014, P < 0.0015 |
Table 6 Comparison of main prognostic indicators among three groups, n (%)/median (interquartile range)
| Indicator | Low SI group | Moderate SI group | High SI group | Statistic | P value | Effect size | Pairwise comparison P values2 |
| Postoperative complications (Clavien-Dindo grading) | χ2 = 31.781 | < 0.001 | Cramer’s V = 0.274 | P = 0.0033, P < 0.0014, P = 0.0245 | |||
| No complications | 48 (61.5) | 32 (36.0) | 8 (17.8) | ||||
| Grade I | 18 (23.1) | 25 (28.1) | 12 (26.7) | ||||
| Grade II | 9 (11.5) | 21 (23.6) | 13 (28.9) | ||||
| Grade III | 3 (3.8) | 8 (9.0) | 7 (15.6) | ||||
| Grade IV | 0 (0.0) | 3 (3.4) | 3 (6.7) | ||||
| Grade V | 0 (0.0) | 0 (0.0) | 2 (4.4) | ||||
| Severe complications (≥ grade III) | 3 (3.8) | 11 (12.4) | 12 (26.7) | χ2 = 12.581 | 0.002 | Cramer’s V = 0.244 | P = 0.0633, P < 0.0014, P = 0.0425 |
| 30-day postoperative mortality | 0 (0.0) | 0 (0.0) | 2 (4.4) | Fisher’s exact test | 0.039 | ||
| ICU admission rate | 15 (19.2) | 42 (47.2) | 34 (75.6) | χ2 = 32.171 | < 0.001 | Cramer’s V = 0.390 | P < 0.0013, P < 0.0014, P = 0.0035 |
| Mechanical ventilation time (hours) | 8.5 (4.2-18.6) | 22.4 (12.8-38.7) | 48.2 (28.6-72.4) | H = 56.8 | < 0.001 | ε2 = 0.268 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Hospital stays (days) | 12.5 (8.2-18.4) | 16.8 (11.2-24.6) | 23.7 (15.8-35.2) | H = 32.4 | < 0.001 | ε2 = 0.153 | P = 0.0093, P < 0.0014, P = 0.0185 |
Table 7 Comparison of secondary prognostic indicators among three groups, mean ± SD/n (%)
| Indicator | Low SI group | Moderate SI group | High SI group | Statistic | P value | Effect size | Pairwise comparison P values2 |
| Postoperative hemoglobin changes (g/L) | |||||||
| 24 hours postoperative | 106.8 ± 16.4 | 84.2 ± 14.7 | 68.9 ± 13.2 | F = 89.6 | < 0.001 | η2 = 0.461 | P < 0.0013, P < 0.0014, P < 0.0015 |
| 48 hours postoperative | 109.2 ± 15.8 | 89.6 ± 15.1 | 74.3 ± 14.6 | F = 78.4 | < 0.001 | η2 = 0.428 | P < 0.0013, P < 0.0014, P < 0.0015 |
| 72 hours postoperative | 112.4 ± 16.2 | 95.7 ± 16.8 | 81.2 ± 15.9 | F = 64.7 | < 0.001 | η2 = 0.382 | P < 0.0013, P < 0.0014, P < 0.0015 |
| Reoperation rate | 2 (2.6) | 8 (9.0) | 9 (20.0) | χ2 = 8.741 | 0.013 | Cramer’s V = 0.203 | P = 0.0963, P = 0.0034, P = 0.0845 |
| Reoperation causes | Fisher’s exact test | 0.024 | |||||
| Postoperative hemorrhage | 1 (1.3) | 5 (5.6) | 6 (13.3) | ||||
| Abdominal infection | 1 (1.3) | 2 (2.2) | 2 (4.4) | ||||
| Pancreatic fistula management | 0 (0.0) | 1 (1.1) | 1 (2.2) | ||||
| mRS score (at discharge) | χ2 = 28.461 | < 0.001 | Cramer’s V = 0.259 | P = 0.0063, P < 0.0014, P = 0.0215 | |||
| 0 points (completely asymptomatic) | 52 (66.7) | 38 (42.7) | 12 (26.7) | ||||
| 1 point (no significant functional deficit) | 18 (23.1) | 28 (31.5) | 14 (31.1) | ||||
| 2 points (mild functional deficit) | 6 (7.7) | 15 (16.9) | 11 (24.4) | ||||
| 3 points (moderate functional deficit) | 2 (2.6) | 6 (6.7) | 5 (11.1) | ||||
| 4 points (moderate to severe functional deficit) | 0 (0.0) | 2 (2.2) | 1 (2.2) | ||||
| 5 points (severe functional deficit) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Table 8 Multivariate logistic regression analysis of factors affecting severe postoperative complications
| Variable | Univariate analysis | Multivariate analysis | ||
| OR (95%CI) | P value | OR (95%CI) | P value | |
| Shock index (continuous variable) | 3.68 (2.15-6.28) | < 0.001 | 2.34 (1.25-4.38) | 0.008 |
- Citation: Wang ZJ, Zheng CM, Zhou JH. Predictive value of preoperative shock index for postoperative outcomes in traumatic splenic rupture patients undergoing splenectomy. World J Gastrointest Surg 2026; 18(4): 117517
- URL: https://www.wjgnet.com/1948-9366/full/v18/i4/117517.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i4.117517
